Skip to main content
. 2024 Nov 15;16(11):6581–6592. doi: 10.62347/NFCD8953

Table 1.

Comparison of clinical data between the favorable and adverse outcome groups

Factor Favorable outcome group (n = 249) Adverse outcome group (n = 138) χ2 Value P Value
Age
    ≥ 40 years 105 (42.17%) 80 (57.97%) 8.886 0.003
    < 40 years 144 (57.83%) 58 (42.03%)
Parity
    Primiparous 115 (46.18%) 73 (52.9%) 1.602 0.206
    Multiparous 134 (53.82%) 65 (47.1%)
Gravidity
    ≥ 2 times 137 (55.02%) 77 (55.8%) 0.022 0.883
    < 2 times 112 (44.98%) 61 (44.2%)
History of miscarriage
    Yes 85 (34.14%) 52 (37.68%) 0.488 0.485
    No 164 (65.86%) 86 (62.32%)
Pre-pregnancy BMI
    < 18 kg/m2 47 (18.88%) 19 (13.77%) 12.232 0.002
    18-24.9 kg/m2 162 (65.06%) 76 (55.07%)
    ≥ 25 kg/m2 40 (16.06%) 43 (31.16%)
Gestational weight gain
    < 15 kg 70 (28.11%) 50 (36.23%) 3.42 0.181
    15-20 kg 119 (47.79%) 63 (45.65%)
    > 20 kg 60 (24.1%) 25 (18.12%)
Education level
    High school or below 63 (25.3%) 39 (28.26%) 3.212 0.201
    College/Undergraduate 164 (65.86%) 80 (57.97%)
    Graduate or above 22 (8.84%) 19 (13.77%)
Mode of conception
    Assisted reproduction 129 (51.81%) 90 (65.22%) 6.5 0.011
    Natural conception 120 (48.19%) 48 (34.78%)
Family history of diabetes
    Yes 20 (8.03%) 14 (10.14%) 0.495 0.482
    No 229 (91.97%) 124 (89.86%)
Gestational hypertension
    Yes 12 (4.82%) 15 (10.87%) 5.008 0.025
    No 237 (95.18%) 123 (89.13%)
Gestational diabetes
    Yes 15 (6.02%) 18 (13.04%) 5.609 0.018
    No 234 (93.98%) 120 (86.96%)
Chorionicity
    Dichorionic twins 209 (83.94%) 110 (79.71%) 1.095 0.295
    Monochorionic twins 40 (16.06%) 28 (20.29%)

Note: BMI, Body Mass Index.